Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Statements of Operations (Unaudited)

v3.26.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 6 Months Ended
Apr. 30, 2026
Apr. 30, 2025
Apr. 30, 2026
Apr. 30, 2025
Income Statement [Abstract]        
Revenue
Operating expenses:        
Research and development expenses (including non-cash stock-based compensation expenses of $286, $417, $624 and $814, respectively) 1,258 1,322 2,360 2,874
General and administrative expenses (including non-cash stock-based compensation expenses of $379, $571, $837 and $1,229, respectively) 1,389 1,681 3,003 3,515
Total operating expenses 2,647 3,003 5,363 6,389
Loss from operations (2,647) (3,003) (5,363) (6,389)
Interest income 111 190 242 363
Net loss (2,536) (2,813) (5,121) (6,026)
Less: Net loss attributable to noncontrolling interest (20) (23) (40) (52)
Net loss attributable to common shareholders $ (2,516) $ (2,790) $ (5,081) $ (5,974)
Net loss per common share attributable to common shareholders:        
Basic $ (0.07) $ (0.09) $ (0.15) $ (0.19)
Diluted $ (0.07) $ (0.09) $ (0.15) $ (0.19)
Weighted average common shares outstanding:        
Basic 33,593 32,202 33,413 32,200
Diluted 33,593 32,202 33,413 32,200